Idiopathic pulmonary fibrosis: What primary care physicians need to know

Abstract

Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age 60, has a predilection for men, and is often fatal. The condition is still underappreciated by pulmonologists and primary care physicians. This article attempts to close that information gap by reviewing the natural course of IPF and presenting an algorithmic approach to diagnosis and treatment based on evidencebased international guidelines. New treatment options are briefly discussed, to raise awareness of new medications that target pulmonary fibrosis.